Experts Discuss Use Of New TB Drug Bedaquiline

Global Health Technologies Coalition’s “Breakthroughs”: New TB drug bedaquiline: Weighing the benefits against the risks
The blog interviews Laia Ruiz Mingote and Dorothy Namutamba, co-chairs of the Community Research Advisors Group (CRAG), and Mike Watson Frick, the TB/HIV program officer at the Treatment Action Group, about the benefits and risks of using the new drug bedaquiline to treat TB (Chmiola, 8/20).